You have 9 free searches left this month | for more free features.

F508del

Showing 1 - 25 of 4,260

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cystic Fibrosis Trial (ELX/TEZ/IVA, IVA)

Recruiting
  • Cystic Fibrosis
  • Gent, Belgium
  • +18 more
Feb 2, 2023

Cystic Fibrosis Trial (ELX/TEZ/IVA, IVA)

Approved for marketing
  • Cystic Fibrosis
  • (no location specified)
Jul 8, 2021

Cystic Fibrosis Trial in Germany (LUM, LUM/IVA, IVA)

Completed
  • Cystic Fibrosis
  • Berlin, Germany
  • +4 more
Nov 8, 2021

Orkambi Treatment in 2 to 5 Year Old Children With CF

Completed
  • Cystic Fibrosis
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Dec 1, 2021

Cystic Fibrosis Trial in Canada, United States (LUM/IVA)

Active, not recruiting
  • Cystic Fibrosis
  • Birmingham, Alabama
  • +22 more
Nov 30, 2022

Lumacaftor/Ivacaftor on F508del Homozygous Cystic Fibrosis

Completed
  • Cystic Fibrosis
  • Lumacaftor, Ivacaftor Drug Combination
  • (no location specified)
Feb 2, 2021

Cystic Fibrosis Trial in Worldwide (VX-121/TEZ/D-IVA, ELX/TEZ/IVA, IVA)

Active, not recruiting
  • Cystic Fibrosis
  • Birmingham, Alabama
  • +169 more
Dec 22, 2022

Lumacaftor/Ivacaftor in Cystic Fibrosis Homozygote for F508del

Recruiting
  • Cystic Fibrosis in Children
    • Düsseldorf, Germany
    • +1 more
    Nov 9, 2020

    Cystic Fibrosis Trial in Worldwide (VX-371 + HS, Hypertonic saline, Placebo)

    Completed
    • Cystic Fibrosis
    • VX-371 + HS
    • +4 more
    • Little Rock, Arkansas
    • +39 more
    Jul 8, 2021

    Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA)

    Completed
    • Cystic Fibrosis
    • Adelaide, Australia
    • +18 more
    Aug 24, 2022

    Cystic Fibrosis Trial in Worldwide (TEZ/IVA, IVA)

    Active, not recruiting
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +54 more
    Oct 28, 2022

    Cystic Fibrosis Trial in Canada, United States (LUM, IVA)

    Completed
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +26 more
    Nov 26, 2021

    Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA, Placebo (matched to ELX/TEZ/IVA))

    Completed
    • Cystic Fibrosis
    • Nedlands, Australia
    • +33 more
    Jul 1, 2022

    Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA, Placebo (matched to ELX/TEZ/IVA))

    Recruiting
    • Cystic Fibrosis
    • Innsbruck, Austria
    • +89 more
    Dec 20, 2022

    Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, TEZ/IVA, IVA)

    Completed
    • Cystic Fibrosis
    • Chermside, Australia
    • +34 more
    Jul 23, 2021

    Cystic Fibrosis Trial in United States (Losartan, )

    Terminated
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +3 more
    Nov 12, 2020

    Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA)

    Active, not recruiting
    • Cystic Fibrosis
    • Nedlands, Australia
    • +33 more
    Feb 4, 2022

    Cystic Fibrosis Trial in Worldwide (VX-121/TEZ/D-IVA, ELX/TEZ/IVA, IVA)

    Recruiting
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +128 more
    Aug 24, 2022

    Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA)

    Completed
    • Cystic Fibrosis
    • Tucson, Arizona
    • +83 more
    Jan 20, 2023

    Cystic Fibrosis Trial in Canada, United States (LUM/IVA)

    Completed
    • Cystic Fibrosis
    • Palo Alto, California
    • +19 more
    Jul 15, 2020

    Cystic Fibrosis Trial (ELX/TEZ/IVA, IVA)

    Approved for marketing
    • Cystic Fibrosis
    • (no location specified)
    Nov 19, 2019

    Cystic Fibrosis (CF) Trial in Worldwide (Galicaftor, Placebo, Navocaftor)

    Active, not recruiting
    • Cystic Fibrosis (CF)
    • Mobile, Alabama
    • +46 more
    Oct 20, 2022

    Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA, TEZ/IVA)

    Completed
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +92 more
    Jun 11, 2021

    Cystic Fibrosis Trial in Worldwide (LUM/IVA)

    Completed
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +60 more
    Apr 27, 2021